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Dendritically Released Peptides Act
as Retrograde Modulators of Afferent Excitation
in the Supraoptic Nucleus In Vitro
Samuel B. Kombian, Didier Mouginot, the pituitary stalk was followed by a decrease in sponta-
neous activity (Barker et al., 1971; Nicoll and Barker,and Quentin J. Pittman
1971), an effect that was thought to be mediated byNeuroscience Research Group
recurrent inhibitory collaterals. This is unlikely to be theUniversity of Calgary
case, since recurrent collaterals are rare in this nucleusCalgary, Alberta T2N 4N1
(Mason et al., 1984; Pow and Morris, 1988, 1989), andCanada
the silent period after antidromic invasion can be ac-
counted for by a long after-hyperpolarization (for review,
see Renaud and Bourque, 1991). Furthermore, OXT en-
Summary hances the activity of SON magnocellular neurons both
in vivo (Freund-Mercier and Richard, 1981; Moos and
Oxytocin (OXT) and vasopressin (VP) are known to Richard, 1989) and in vitro (Yamashita et al., 1987), pre-
be released from dendrites of magnocellular neurons. sumably via activation of OXT/VP receptors found in
this nucleus (Brinton et al., 1984a, 1984b; Van LeeuwenHere, we show that these peptides reduced evoked
et al., 1985; Freund-Mercier et al., 1988). In addition,EPSCs by a presynaptic mechanism, an effect blocked
OXT has been shown tocause an increase in intracellularby peptide antagonists and mimicked by inhibition of
calcium (Lambert et al., 1994) and to modulate GABAAendogenous peptidases. Dendritic release of peptides,
receptor-mediated responses in SON cells (Brussaardelicited with depolarization achieved by high frequency
et al., 1996).stimulation of afferents or with current injection into
While these neuropeptide-induced postsynaptic ac-an individual neuron, induced short-term synaptic de-
tions can modulate intrinsic membrane properties ofpression similar to that seen following exogenous pep-
magnocellular and other CNS neurons, there is over-tide application and was prevented by peptide antago-
whelming evidence that excitatory and inhibitory inputsnists. Thus, dendritically released peptides depress
to the SON regulate the excitability of neurosecretoryevoked EPSCs in magnocellular neurons by activating
neurons both in vivo and in vitro (Renaud and Bourque,presynaptic OXT and/or VP receptors. Such a retro-
1991; Armstrong, 1995). These inputs have themselvesgrade modulatory action on afferent excitation may
been shown to be subject to modulation by activationserve as a feedback mechanism to permit peptidergic
of presynaptic GABAB receptors (Kombian et al., 1996).neurosecretory neurons to autoregulate their own ac-
Altering the neurotransmitter-mediated control of neu-tivity.
rosecretory cells by locally released OXT/VP would pro-
vide a means by which SON neurons could autoregulate
their electrical activity and hence alter hormonal se-Introduction
cretion.
Taking advantage of the fact that neuropeptides inNeurotransmission is classically achieved by transmit-
the SON are released mainly from dendrites, we usedters released from axon terminals to activatepostsynap-
this nucleus to determine if dendritically released pep-tic receptors. A recent concept is that neurotransmitters
tides modulate afferent excitation. Here, we providecan also be released from dendrites to produce local
electrophysiological evidence that dendritically releasedmodulation of synaptic transmission (for review, see
neuropeptides from a single magnocellular cell and/orConde, 1992; Pucak and Grace, 1994). The neuropep-
from a population of cells can serve as retrograde trans-
tides oxytocin (OXT) and vasopressin (VP) are synthe-
mitters, whereby they act on presynaptic afferents to
sized in hypothalamic supraoptic magnocellular neu-
regulate the magnitude of excitatory inputs onto SON.
rons and are released from axon terminals into the
general circulation, where they act as hormones. In addi- Results
tion to this classical way of release, these neuropeptides
can also be released locally to function as neuromodula- OXT and VP Depress Evoked Non-NMDA
tors in the supraoptic nucleus (SON; for review, see Receptor-Mediated Excitatory
Hatton, 1990; Armstrong, 1995). The main source of en- Postsynaptic Currents
dogenous neuropeptides in the SON is thought to be Stimulation of the hypothalamic region dorso-medial to
magnocellular cell dendrites, where vesicles containing the SON elicits depolarizing postsynaptic responses
OXT or VP (Castel and Morris, 1988) and release profiles that are mediated by glutamate and GABAA receptor
(Morris and Pow, 1993) have been demonstrated. Den- activation (Randle et al., 1986; Gribkoff and Dudek, 1990;
dritic release of neuropeptides was shown to be cal- Kombian et al., 1996). In the presence of the GABAA
cium-dependent and TTX-resistant (Di Scala-Guenot et chloride ionophore blocker picrotoxin (50 mM), pure non-
al., 1987; Ludwig and Landgraf, 1992), suggesting that NMDA receptor-mediated excitatory postsynaptic po-
the dendrites of magnocellular neurons contain the nec- tentials/currents (EPSPs/EPSCs) can be recorded (Grib-
essary machinery to release neuropeptides during ap- koff and Dudek, 1990; Kombian et al., 1996), responses
propriate stimulation. that were blocked by the non-NMDA receptor-selective
A role for the neuropeptides in the regulation of SON antagonist NBQX (1 mM, 91.4% 6 3.0% reduction; Fig-
neuronal activity was first postulated when antidromic ure 1A). The effects of OXT and VP were investigated on
this non-NMDA receptor-mediated excitatory response.invasion of neuronal somata from the axons located in
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Figure 1. Activation of OXT and VP Recep-
tors Reversibly Depresses Evoked Pharma-
cologically Isolated EPSCs
(A) Stimulation of afferent fibers into SON in
the presence of picrotoxin (50 mM) evoked a
pure EPSC in a magnocellular neuron voltage
clamped at 280 mV (upper panel). Sample
synaptic traces (average of four to six individ-
ual responses) illustrate a typical reversible
OXT-induced depression of evoked EPSC
amplitude and the complete blockade by
NBQX (1 mM). The lower panel shows a time-
effect plot indicating where the above sample
synaptic traces were taken before (a), during
(b), and after OXT (c) and during NBQX (d)
application. In this and all other figures, data
points shown represent averages of re-
sponses taken in a minute.
(B) A bar graph summarizing the effect of OXT
(1 mM; n 5 14) and NBQX (1 mM; n 5 7) on
the evoked EPSC amplitude.
(C) OXT (closed circles) and its agonist, OXT-
AG (open squares) both induce a concentra-
tion-dependent depression of the evoked
EPSC amplitude. The number by each point
indicates the number of neurons tested at
that concentration. Note that OXT demon-
strated a slightly higher potency at de-
pressing EPSC than the agonist,but with sim-
ilar efficacy.
(D) Representative averaged EPSCs illustrating a reversible VP-induced depression of evoked EPSCs (upper panel). The lower panel is a bar
graph showing the effect of VP (1 mM) on six neurons tested. Asterisk 5 p , 0.05.
OXT or OXT-AG ([Thr4, Gly7]-oxytocin; Lowbridge et the OXT-induced synaptic depression (7.4% 6 2.1%;
n 5 5; p , 0.05 versus OXT alone). The OXT-ANT hadal., 1977), a specific agonist for OXT receptors, was
applied to 53 neurons voltage clamped at 280 mV. In no effect on the EPSC by itself (9.3% 6 7.6% enhance-
ment of EPSC amplitude; n 5 5; p . 0.05 versus control;20% of these cells, the peptides induced an inward
current (10±20 pA). Irrespective of this postsynaptic ef- Figures 2A and 2B). In a similar way, 10 mM Manning
compound (MC; [d(CH2)51, O-Me-Tyr2, Arg8]-vasopressin;fect, in 44 of the 53 neurons (z80%), 1 mM OXT or
2 mM OXT-AG caused a decrease in EPSC amplitude Kruszynski et al., 1980), an antagonist for both OXT and
VP receptors, had little effect on the synaptic response(Figures 1A and 1C). In the remaining nine neurons
(z20%), EPSC amplitude was not affected by the pep- (4.9% 6 5.3% depression; n 5 6; p . 0.05 versus control;
Figure 2D). In its presence, however, 1 mM OXT de-tides. The onset of the depressant effect occurred at
z2 min, peaked at z4±6 min, and recovered to baseline pressed the evoked EPSC by only 2.9% 6 7.7% (n 5
6; p , 0.05 versus OXT alone; Figures 2C and 2D).after 10±25 min following washout. The depressant ef-
fect of both peptides was concentration-dependent and The agonist mimicry of OXT effects, together with
the blockade of OXT-induced synaptic depression byappeared to be maximal around 1 mM (Figure 1C). In
current clamp experiments, OXT also depressed the antagonists, indicate that OXT acts on OXT receptors
in the SON to decrease excitatory synaptic responses.evoked EPSPs (18.1% 6 3.5%; n 5 5). Similar to the
actions of OXT or OXT-AG, 1 mM VP also reversibly The lack of significant effect of both antagonists by
themselves on evoked EPSCs suggests that OXT/VPdepressed the evoked EPSCs by 33.7% 6 5.8%; (n 5
6; p , 0.05 versus control; Figure 1D) without any post- receptors are not tonically activated under basal condi-
tions.synaptic effects. Thus, exogenously applied OXT and
VP depress excitatory synaptic transmission in the SON.
Because both peptides have similar effects on evoked OXT-Induced Synaptic Depression Is Mainly
via Presynaptic MechanismsEPSCs, we used OXT as a representative neurohypo-
physial peptide to study further this modulation of excit- Although the majority of neurosecretory cells in this
study did not respond to these peptides with an appar-atory synaptic transmission.
To examine the selectivity of this effect, the pharma- ent postsynaptic effect, the OXT-mediated depression
of EPSCs could be due to either post- or presynapticcology of the OXT receptors was studied using antago-
nists. In control experiments, 1 mM OXT depressed the mechanisms. Different experiments were performed to
determine the locus of action of this peptide. First, be-EPSC amplitude by 33.4% 6 4.2% (n 5 14). As shown
in Figure 2A, bath application of 10 mM OXT-ANT, an cause OXT may produce postsynaptic effects that could
contribute to the synaptic depression but may not beOXT receptor-selective antagonist ([des-glycinamide9,
d(CH2)51, O-Me-Tyr2, Thr4,Orn8]-vasotocin; Elands et al., detected at the holding potential (280 mV), we tested
OXT's action on voltage-activated conductances. In1988; Manning and Sawyer, 1989) significantly reduced
Peptides as Retrograde Modulators of EPSCs
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Figure 2. OXT-Induced Synaptic Depression
Is Blocked by OXT/VP Antagonists
(A) Averaged sample EPSCs obtained at
timesdenoted by letters in lower panel,show-
ing that the OXT receptor antagonist OXT-
ANT (10 mM) blocks OXT-induced synaptic
depression in a magnocellular neuron. The
lower panel is a time-dependent plot of the
action of OXT in the presence of OXT-ANT.
(B) A bar graph summarizing the effect of OXT
in the presence of the antagonist (OXT-ANT)
in five neurons tested.
(C) The OXT/VP receptor antagonist Manning
compound (MC, 10 mM) also blocks the OXT-
induced synaptic depression in these cells.
Upper panel illustrates typical average EPSCs
taken before (a), during (b), and after (c) MC
application.
(D) A bar graph summarizing the block by MC
(10 mM; n 5 6) of OXT-induced depression of
the evoked EPSC.
cells in which 1 mM OXT depressed the evoked EPSC to alter the paired pulse ratio (PPR) of two consecutive
EPSCs, a protocol frequently used as a test of presynap-(Figure 3A), the current-voltage relationship (I-V curves,
tested from 2120 to 230 mV at 4.5 mV/s) in control and tic action of drugs (Zucker, 1989; Manabe et al., 1993). A
pair of EPSCs was evoked 50 ms apart, an interstimulusin the presence of 1 mM OXT were superimposable over
the entire voltage range tested (Figure 3B). Secondly, interval that was previously shown to produce a consis-
tent facilitation of the second EPSC in this preparationOXT did not appear to interact with postsynaptic non-
NMDA glutamate receptors, as it did not affect AMPA- (Kombian et al., 1996). The ratio of the second EPSC
amplitude to that of the first (2/1) was determined asinduced currents in these cells (104 6 29 pA in control
versus 105 6 34 pA in the presence of 1 mM OXT; p . the PPR. In control condition, the second EPSC was
always bigger than the first (PPR 5 1.75 6 0.3; n 5 4;0.05; n 5 5; Figure 3C). These results suggest that OXT
may act at a presynaptic site to cause a decrease in the Figures 3D and 3E), giving rise to a paired pulse facilita-
tion (PPF). In the presence of OXT-AG (5 mM), the ampli-evoked EPSC. To test for a possible presynaptic locus
of action, we examined the ability of OXT and OXT-AG tudes of both EPSCs were decreased but the second
Figure 3. OXT-Induced Depression of EPSCs
Is Mediated by Presynaptic Mechanisms
(A) Sample EPSCs showing that OXT revers-
ibly depressed the evoked EPSC without
changing the holding current.
(B) Superimposed I-V curves generated in the
same cell in as (A), showing that OXT (1 mM),
whiledepressing the evoked EPSC(A), has no
effect on the steady-state current activated
over a wide voltage range (2120 to 230 mV).
(C) Chart records of AMPA-induced inward
currents in control (30 s; first two traces), in
the presence of OXT (2 mM; third trace), and
following 10 min washout of OXT (fourth
trace). OXT was applied for 4 min prior to the
third AMPA application.
(D) Sample synaptic responses elicited by a
pair of stimuli given at 50 ms intervals show-
ing that OXT-AG-induced EPSC depression
is accompanied by a change in paired pulse
ratio (PPR) between two consecutive EPSCs.
(E) A bar chart generated by normalizing all
PPRs to their control values illustrates OXT
(5 mM; n 5 4) and OXT-AG (5 mM; n 5 4) both
induced significant increases in the PPR. As-
terisk 5 p , 0.05.
Neuron
906
EPSC was less depressed, resulting in a larger PPF
(PPR 5 2.1 6 0.50; n 5 4) that was reversible upon
washout of the drug (Figures 3D and 3E). Similar effects
were seen with OXT (5 mM; Figure 3E).
Taken together, these data indicate that OXT acts
mainly at a presynaptic locus to cause a decrease in
synaptic transmission.
Endogenously Released Peptides Are Efficiently
Degraded by Aminopeptidases
If the above results demonstrated that exogenously
applied OXT/OXT-AG presynaptically inhibited EPSCs
evoked in SON neurons by activation of OXT/VP recep-
tors, then due to the close apposition of afferent termi-
nals with dendritic shafts (for review, see Armstrong,
1995), one would predict that OXT receptor antagonists
would increase the size of EPSCs by removing a tonic
inhibitory effect of the neuropeptides. However, neither
MC nor OXT-ANT caused an enhancement of EPSC am-
plitude (see Figure 2), suggesting that under our re-
cording conditions, there was little endogenous release
of OXT. An alternate possibility is that an inhibitory ac-
tion of basally released peptides was prevented by an
efficient removal mechanism such as enzymatic degra-
dation (Claybaugh and Uyehara, 1993; Saleh etal., 1996).
We therefore tested the hypothesis that OXT is under
efficient peptidasedegradation by examining the effects
of peptidase inhibitors on the evoked EPSCs. Although
OXT and VP are degraded mainly by aminopeptidases
but not endopeptidases (Burbach and Lebouille, 1983;
Figure 4. An Aminopeptidase Inhibitor, Amastatin (AMAS), MimicsStark et al., 1989), experiments were done with inhibitors
the Synaptic Depressant Effect of OXTof both peptidases, with the endopeptidase inhibitor
(A) Representative averaged EPSCs (a±c) are presented, illustrating(phosphoramidon) serving as a control. In tenmagnocel-
AMAS-induced depression of evoked EPSCs (upper panel) and
lular neurons, the aminopeptidase inhibitor amastatin blockade of AMAS's effect by pretreatment with an OXT/VP receptor
(AMAS, 10 mM) reversibly depressed the evoked EPSC antagonist (Manning compound, MC) as illustrated in (c), (d), and
by 26.5% 6 3.4% (Figure 4A), and repeated application (e) (middle panel). The lower panel is a time-effect plot of the same
cell showing time points where the representative traces were taken.on the same cell caused a consistent level of synaptic
(B) A bar chart summarizing the effect of AMAS (10 mM; n 5 10),depression (n 5 3; data not shown). In the presence of
phosphoramidon (10 mM; n 5 5), and AMAS in the presence of MCthe peptide antagonist MC (10 mM), the AMAS-induced
(10 mM; n 5 5). Asterisk 5 p , 0.05.
reduction in the EPSC amplitude was abolished (1.6% 6
3.4% reduction, n 5 5; p , 0.01 versus AMAS alone;
Figures 4A and 4B). On the other hand, 10 mM phos- release, would saturate aminopeptidases, resulting in
phoramidon, at a concentration known to be effective detectable actions of peptides. To test this hypothesis,
in inhibiting endopeptidases (Saleh et al., 1996), had no we attempted toenhance peptide release through depo-
effect on the evoked EPSCs in these cells, producing a larization initiated by high frequency stimulation (HFS;
decrease of only 0.2% 6 4.6% (n 5 5; Figure 4B). 100 Hz; 1 s) of afferents. Prolonged depolarization, such
The lack of effect of a known endopeptidase inhibitor, as that resulting from this stimulus, has been shown to
phosphoramidon, coupled with the block of the AMAS- be necessary and efficient in inducing peptide release
induced synaptic depression by MC are consistent with both from dendrites (Wagner et al., 1991, 1993) and from
an action of AMAS on aminopeptidases to enhance ex- OXT/VP axon terminals in the pituitary (Dreifuss et al.,
tracellular OXT or VP levels. These results suggest that 1971; Bicknell, 1988). In these experiments, following
endogenous peptides can activate OXT/VP receptors stable baseline EPSC recordings, neurons were taken
under appropriate conditions to depress synaptic trans- out of voltage clamp mode into current clamp mode and
mission. afferents tetanized. The subsequent massive depolar-
ization of the recorded neuron, in addition to other SON
neurons, was expected to trigger dendritic release ofEnhancement of Endogenous Peptide Release
Mimics the Effects of Exogenous OXT peptides. The neurons were then quickly voltage clamped
again at 280 mV and EPSCs recorded while monitoringHaving demonstrated an OXT/VP-induced inhibition of
excitatory synaptic transmission and a possible endoge- the holding current and input resistance of the recorded
neuron (see Experimental Procedures). Figure 5A1 illus-nous action of peptides in the SON by the aminopepti-
dase inhibitor experiments, we hypothesized that en- trates a typical response of a magnocellular neuron fol-
lowing the HFS. The EPSC amplitude was decreasedhanced acute peptide release, in contrast to tonic
Peptides as Retrograde Modulators of EPSCs
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Figure 5. High Frequency Stimulation (HFS)
of Afferents to SON Induces a Short-Term
Depression of Evoked EPSCs
(A1) Representative averaged EPSCs (four to
six traces) taken before (left), 4±6 min (mid-
dle), and 20 min (right) after HFS (two bursts
of 100 Hz for 1 s at 10 s intertrain interval).
(A2) A normalized and averaged time-response
plot obtained from ten cells that received the
same HFS as the cell illustrated in (A1). In
this and all other averaged graphs, all EPSCs
were normalized to the mean amplitude of
the five responses prior to HFS. Individual
normalized graphs were then aligned at the
time of HFS (double arrows) and averaged.
(B andC) The HFS-induced short-term synap-
tic depression is blocked by neuropeptide
antagonists. Averaged normalized graphs
showing that OXT-ANT (10 mM; n 5 5) and
Manning compound (MC, 10 mM; n 5 7) both
consistently block the HFS-induced short-
term synaptic depression.
by z40% shortly after the HFS and remained depressed such current injections, SON cells fire action potentials
at 45±55 Hz (Kombian et al., 1996), a frequency knownfor almost 15 min. In 12 neurons tested, initial responses
to the HFS ranged from depression to potentiation of to trigger peptide release (Bicknell, 1988; Drake et al.,
1994). After two to four consecutive such injections (atthe EPSCs, which subsided within 3 min. In ten of these
12 neurons (80%), there was a subsequent decrease in intervals of 10 s), EPSCs were depressed at times long
after any discernable changes in the postsynaptic char-EPSC amplitude, ranging from 14%±50% (37% 6 4.4%
reduction; p , 0.001 versus control; Figure 5A), an effect acteristics of the recorded cell (Figure 6A2). This synap-
tic depression was observed in seven cells tested andthat peaked between 3±6 min post-HFS and recovered
to baseline level in z15±20 min post-HFS. Of the re- amounted to a reduction of 5%±30% (18.5% 6 2.9%;
Figures 6A2 and 6B). It was fully reversible and had amaining two cells, the HFS produced a 10% increase in
EPSC amplitude in one cell while not affecting the other. time course similar to that following HFS or exogenous
OXT application. It was also prevented when slices wereThe total change induced in all 12 cells tested was 30.2 6
5.9 (p , 0.05 compared to control). pretreated with OXT antagonists (OXT-ANT, 3.9% 6
3.0% reduction, n 5 4; data not shown; and MC, 3.5% 6To determine if the HFS-induced synaptic depression
was indeed due to the release of peptides, we repeated 2.3% reduction, n 5 4; p , 0.05 under both antagonist
versus control depolarization-induced depression; Fig-these experiments in the presence of MC or OXT-ANT,
both OXT receptor antagonists that had been shown to ure 6C).
The close correlation in the synaptic depressionblock exogenous OXT-induced synaptic depression. In
the presence of 10 mM OXT-ANT, the same stimulation caused by exogenous OXT, HFS, and prolonged depo-
larization of a single cell, in addition to its blockadeno longer caused synaptic depression in all the cells
tested (n 5 5; Figure 5B). In these neurons pretreated by OXT receptor antagonists (OXT-ANT and MC) are
consistent with the possibility that dendritically releasedwith 10 mM OXT-ANT, the HFS induced only 3.3% 6
9.2% reduction in EPSC amplitude (p , 0.02 versus neuropeptides act on presynaptic afferents to decrease
evoked EPSCs.control HFS; Figure 5B). Similarly, in the presence of 10
mM MC, the HFS did not significantly depress the EPSC
in seven cells tested (0.2% 6 6% depression; p , 0.01 Discussion
versus control HFS; Figure 5C).
Although peptides in the SON have been shown to be Taken together, the present results provide evidence
that neuropeptides released from dendrites of magno-released predominantly from dendrites (Pow and Morris,
1988, 1989), we cannot rule out the possibility that exci- cellular neurons retrogradely depress excitatory synap-
tic transmission. These peptides act mainly on OXT re-tation of a neuronal population (HFS protocol) can re-
lease OXT/VP either from possible sparse collaterals ceptors located on the presynaptic glutamate terminals
to cause a decrease in glutamate release.between magnocellular neurons or from different hypo-
thalamic inputs. To test this possibility, we asked if an
individual neurosecretory cell would release enough Post- and Presynaptic Actions of Peptides
in the SONpeptide to produce the observed synaptic depression.
We tested this hypothesis by depolarizing the recorded A minority of magnocellular neurons responded to OXT
and its agonist but not to VP, with an inward currentneuron with sustained injection of current under current
clamp mode (Figure 6A1). The elicited spikes would be indicating possible activation of postsynaptic OXT re-
ceptors. Postsynaptic effects of OXT have been de-expected to backpropagate throughout the dendrites to
trigger release of their neuropeptide content. Following scribed in the SON where OXT increases both electrical
Neuron
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Figure 6. Firing of Repetitive Action Poten-
tials by Magnocellular Neurons Triggers De-
pression of Evoked EPSCs
(A1) A typical pattern of firing of a magnocel-
lular neuron to sustained (1 s) injection of de-
polarizing current (current clamp mode).
(A2) Representative EPSC traces taken be-
fore (a), after (b), and following (c) recovery
from effects of two to four depolarizations
identical to the one illustrated in (A1). Under
each synaptic response is the membrane re-
sponse to a 20 mV hyperpolarizing pulse ap-
plied 100 ms after synaptic stimulation to
monitor series/access and input resistance.
In the bottom panel is a time-response plot of
evoked EPSCs in this magnocellular neuron
showing the times atwhich therepresentative
traces were taken (double arrow heads indi-
cate depolarizations).
(B) An average time-response plot of normal-
ized EPSCs from eight cells that received
treatment as in (A1).
(C) Normalized averaged time-response plot
obtained from four neurons that were depo-
larized as in (A1) and (B) but in the presence
of MC (10 mM).
activity (Freund-Mercier and Richard, 1981; Yamashita The presynaptic action of the neuropeptides to de-
crease excitatory synaptic transmission contrasts with aet al., 1987; Moos and Richard, 1989) and intracellular
calcium (Lambert et al., 1994; Dayanithi et al., 1996). recent report indicating that exogenous OXT depresses
inhibitory transmission by acting at a postsynaptic siteAs these apparent postsynaptic effects have been well
studied elsewhere and appeared to be independent of (Brussaard et al., 1996). If OXT acts only at the postsyn-
aptic locus to depress inhibitory transmission, then ourthe synaptic effects of the peptides, they were not stud-
ied further. finding that OXT-induced depression of excitatory trans-
mission is mainly achieved by a presynaptic action sug-OXT and VP both depressed pharmacologically iso-
lated EPSCs evoked in the SON in a concentration- gests that this nucleus is endowed with an ability to
modulate excitatory and inhibitory inputs differentially.dependent and reversible fashion. These effects were
most likely produced by activation of OXT receptors as This situation may arise from a separate somato-den-
dritic location of GABAergic and glutamatergic afferentsthey were blocked by selective OXT receptor antago-
nists and mimicked by a selective OXT agonist and by on magnocellular cells (for review, see Armstrong, 1995)
or from an absence of functional peptide receptors onVP, a related peptide that has been shown to bind to
OXT receptors (MuÈ hlethaler and Dreifuss, 1983). Our GABA terminals. Such a difference will enable this nu-
cleus to fine tune its extrinsic inputs as the situationdata suggest a presynaptic locus of action. In the major-
ity of neurosecretory cells, OXT-induced synaptic de- requires to modify magnocellular neuronal activity ap-
propriately.pression was observed without a concomitant postsyn-
aptic response over a wide range of potentials (2120
to 230 mV). The peptides could also decrease synaptic Role for Endogenous Peptides in the SON
In addition to demonstrating that exogenous OXT is abletransmission by directly interacting with the non-NMDA
receptors that mediate the EPSCs, but this did not ap- todepress glutamatergic synaptic transmission, we also
provide evidence that endogenously released peptidespear to be the case, as both neuropeptides affected
neither the amplitude nor the rise time of current induced have the same effect. At first glance, the findings that the
peptide antagonists were without effect when appliedby brief application of AMPA. In order to clarify further
if OXT depressed the evoked EPSCs at a post- or pre- alone did not support this conclusion. One possibility
is that, under our experimental conditions, an efficientsynaptic site, we used a paired pulse protocol, whereby
two successive EPSCs were applied with a fixed interval. degradatory system exists to remove endogenous pep-
tides quickly. This was confirmed by our finding that anThis protocol has been used frequently to demonstrate
that the PPR is significantly altered by drugs and manip- aminopeptidase enzyme inhibitor, AMAS, mimicked the
depressant action of exogenously applied peptides.ulations that change the probability of release of gluta-
mate (Lupica et al., 1992; Manabe et al., 1993). OXT and This effect of AMAS was rapid in onset (z2 min), had a
time course similar to the kinetics of enzyme inhibitionits agonist, concomitant with a decrease in EPSC ampli-
tude, caused an increase in the PPR, suggesting that determined in vivo (Stark et al., 1989), and could be
blocked by OXT antagonist pretreatment. Furthermore,these peptides were acting presynaptically to decrease
glutamate release from afferent terminals. Our data do this effect was specific to the aminopeptidase enzyme
inhibitor, since an endopeptidase inhibitor, phosphor-not allow us to distinguish between an OXT receptor
located on the glutamatergic afferents or on an in- amidon, had no effect. These results provide evidence
that the endogenous neuropeptides OXT and/or VP areterneuron of unknown phenotype.
Peptides as Retrograde Modulators of EPSCs
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tonically released in the SON and their concentration Lightman, 1993; Morris and Pow, 1993), the depolariza-
tion of a magnocellular neuron may also trigger the re-regulated by an aminopeptidase enzyme.
One might question why there should be a mechanism lease of opioid peptides that could be responsible for
or contribute substantially to the EPSC depressionpresent to curtail the action of endogenously released
peptides. One explanation may be that OXT receptors (Weisskopf et al., 1993; Simmons et al., 1995). This latter
alternative seems unlikely, because the decrease inhave been shown to desensitize quickly (Di Scala-
Guenot et al., 1994; Lambert et al., 1994; Dayanithi et EPSC amplitude was completely prevented by treat-
ment with MC, an OXT/VP antagonist. These data indi-al., 1996). We propose that the efficient peptidases may
prevent total desensitization of peptide receptors and cate that the neuropeptides involved in this retrograde
effect activated presynaptic OXT receptors.thus maintain the peptide receptors in a functional state,
allowing acutely released peptides (or exogenous pep- A similar depolarization-induced suppression of inhi-
bition (DSI) of inhibitory synaptic transmission has beentides) to activate the presynaptic OXT/VP receptors to
depress synaptic transmission. reported in the cerebellum at a basket cell±Purkinje cell
synapse as well as at the synapse between two hippo-
campal pyramidal cells (Alger et al., 1996; Glitsch et al.,
Endogenous Peptides as Retrograde 1996). In both cases, a retrograde messenger released
Neuromodulators by the postsynaptic cell was postulated to act on pre-
As indicated above, the action of the aminopeptidase synaptic inhibitory terminals to decrease GABA release.
enzyme will ensure that only under conditions of ele- In the cerebellum, Glitsch et al. (1996) presented evi-
vated local release will endogenous peptides have de- dence that the retrograde messenger was glutamate,
tectable effects such as those seen in response to exog- acting on presynaptic metabotropic receptors to cause
enous neuropeptide application. To trigger such release the decrease in GABA release. In addition, dendritically
of dendritic OXT/VP, we stimulated afferents to the SON released dynorphin from a population of dentate granu-
at high frequency (HFS). The subsequent postsynaptic lar cells has been shown to modulate perforant path
depolarization of the magnocellular neuron induced by excitatory inputs to these cells (Wagner et al., 1993;
massive glutamate release will activate voltage-depen- Drake et al., 1994; Simmons et al., 1995). Although we
dent calcium channels located on somata and/or den- cannot rule out possible depolarization of other nearby
drites (Mills et al., 1994; Fisher and Bourque, 1996) of neurons due to increased extracellular potassium or cell
magnocellular neurons to trigger the exocytotic release coupling, our findings suggest that neuropeptides (other
of peptides (Di Scala-Guenot et al., 1987). Following than opioid peptides) released from the dendrites of a
HFS, most cellsexhibited a relatively long-lasting synap- single neuron in the SON can act as retrograde transmit-
tic depression. The onset, time to peak, and duration of ters to modulate afferent excitation.
these effects were similar to those produced by exoge- The physiological significance of this OXT/VP-induced
nous OXT or VP and were blocked by the selective OXT depression of excitatory synaptic transmission may be
antagonist, thereby suggesting that this synaptic de- critical to the function of the SON. It is well-known that
pression is the result of activation of OXT receptors by under certain physiological conditions, such as during
peptides released from magnocellular neurons. parturition and lactation, there is enhanced release of
High frequency stimulation of afferent fibers could OXT that can, in a positive feedback fashion, increase
cause the release of OXT/VP not only from dendrites of cell firing and increase release of peptides into the gen-
SON cells, but also from collaterals of adjacent cells. In eral circulation (Lambert et al., 1993; Neumann et al.,
addition, peptidergic afferents arising from other hypo- 1993). In addition, OXT, via a possible postsynaptic
thalamic nuclei (Conrad and Pfaff, 1976; Saphier and mechanism, has been shown to decrease GABAA-medi-
Feldman, 1987) may be stimulated and thereby release ated IPSCs (Brussaard et al., 1996). Both of these OXT's
additional OXT/VP. To investigate further the source of actions are excitatory and could result in a ªrun awayº
peptides causing the synaptic depression, a single mag- situation where the cells fire uncontrollably. A presynap-
nocellular neuron was strongly depolarized by sustained tic action of the dendritically released neuropeptides
current injection. This protocol caused the neuron to on afferent excitation will provide a means to prevent
fire action potentials at frequencies of 45±55 Hz, and excessive excitation that may serve to prevent or termi-
backpropagation of these spikes would be expected nate a run away situation in these cells. It is interesting
to trigger dendritic release of peptides (for review, see that during the milk ejection reflex, OXT neurons fire a
Stuart et al., 1997). Such long depolarizations appear to brief burst of action potentials, after which they aresilent
be necessary to trigger OXT and VP release from SON for a few minutes (for review, see Hatton, 1990; Arm-
neurons (Di Scala-Guenot et al., 1987) and seem to be strong, 1995). The depressant effect of OXT reported in
efficient in our preparation, because decreases in EPSC this study may contribute to this silent period and may
amplitudes were observed with a similar time course, help to reset normal firing patterns to maintain magno-
albeit smaller in magnitude and less frequently, than the cellular neurons in an optimal responding state.
HFS-induced depression. This provides evidence that
Experimental Proceduresa single neurosecretory cell is able to release enough
peptide following backpropagation of spikes to over-
All experiments were carried out in accordance with guidelines es-whelm the peptidases and then produce a detectable
tablished by the Canadian Council on Animal Care and were ap-
change in synaptic transmission. However, since opioid proved by the University of Calgary Animal Care Committee. All the
peptides have been shown to colocalize with OXT and techniques used in this study have been reported elsewhere by us
(Kombian et al., 1996).VP in SON cell dendrites (for review, see Chowdrey and
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Slice Preparation Statistics
All data are presented as mean 6 standard error of the mean (SEM).In brief, 400 mm coronal slices were generated from male Sprague-
Dawley rats (25±40 days) and incubated at room temperature (228C) Statistical comparisons were done using ANOVA and paired or un-
paired Student's t test, as appropriate, except when more than twoin artificial cerebrospinal fluid (ACSF [pH 7.3±7.4]) bubbled with
carbogen (5% CO2 and 95% O2). A hemisected slice was then trans- points were compared when ANOVA and a multiple comparison test
was used. p , 0.05 was considered as significant.ferred into a 500 ml recording chamber, where it was submerged
and continuously perfused with prewarmed ACSF (278C±298C) at a
rate of 2±3 ml/min. The composition of the ACSF was NaCl, 126 Acknowledgments
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same solution, to which nystatin (450 mg/ml) in dimethyl sulfoxide
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